Representative before the EPO

Employment test 51 - 200 employees
Company dna d young and co llp
operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Zöe Clyde-Watson has worked on the following 41 EPO patent applications which have been published in the last five years:

EP11815953

FOAMABLE COMPOSITIONS OF STABILIZED CHLORITE

IPC classification:
A61K 9/12, A61K 33/00, A61K 47/30, A61P 17/02
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11820594

SALT COMPOUND

IPC classification:
A61K 31/426, A61P 9/00, A61P 25/00, C07D 277/24
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12760787

POLYPEPTIDES WITH AFFINITY FOR HEAT SHOCK PROTEINS (HSPS) AND HSP ASSOCIATED COMPLEXES (HACS) AND THEIR USE IN DIAGNOSIS AND THERAPY

IPC classification:
A61K 39/00, A61P 35/00, A61P 37/04, C07K 1/22, C07K 7/06, C07K 7/08, C07K 14/00, C07K 14/47, C07K 19/00, C12N 15/11, G01N 33/53, G01N 33/543, G01N 33/574
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12717824

DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA

IPC classification:
A61K 31/706, A61K 31/7068, A61P 35/02
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12737648

AMIDO-PYRIDYL ETHER COMPOUNDS AND COMPOSITIONS AND THEIR USE AGAINST PARASITES

IPC classification:
A01N 37/18, A61K 31/44, A61K 31/4433, A61P 33/00, A61P 33/10, A61P 33/14, C07D 213/18
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT GRANTED
EP12732700

VINYL ALCOHOL POLYMERS WITH SILANE SIDE CHAINS

IPC classification:
C08F 230/08
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
HGF Limited
Status:
GRANT OF PATENT INTENDED
EP12716555

PARTICLES WITH HYDROXYL VINYLIC COPOLYMER COATING SENSITIVE TO IONIC STRENGTH

IPC classification:
C11D 3/37, C11D 17/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
HGF Limited
Status:
APPLICATION WITHDRAWN
EP12716553

NOVEL COMPOSITE

IPC classification:
C11D 3/37, C11D 17/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
HGF Limited
Status:
APPLICATION WITHDRAWN
EP12748346

JAK P13K/mTOR COMBINATION THERAPY

IPC classification:
A61K 31/4188, A61K 31/7064, A61P 35/00
Applicant:
Novartis Pharma AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12759857

DECITABINE DERIVATIVE FORMULATIONS

IPC classification:
A61K 9/00, A61K 9/19, A61K 31/7068, A61K 47/10, A61K 47/20, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12772575

PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF

IPC classification:
A01N 25/00, A61K 31/42, A61P 33/00
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12775538

BACTERIUM FOR USE AS A PROBIOTIC FOR NUTRITIONAL AND MEDICAL APPLICATIONS

IPC classification:
A61K 35/74, A61P 1/00, A61P 37/00
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12795175

METHOD OF TREATING A PROLIFERATIVE DISEASE

IPC classification:
A61K 31/506, A61P 35/00
Applicant:
Novartis AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
Sewkian Rudge, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13178264

Immunomodulation by IAP Inhibitors

IPC classification:
A61K 31/421, A61K 31/427, A61K 31/437, A61K 31/4439, A61K 31/506, A61K 39/00, A61K 39/39, A61P 37/02
Applicant:
Novartis AG
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION REQUESTED
EP12798095

COMPOSITIONS COMPRISING AN ARYL PYRAZOLE AND A SUBSTITUTED IMIDAZOLE, METHODS AND USES THEREOF

IPC classification:
A61K 31/415, A61K 31/4164, A61K 45/06, A61P 33/14
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12798570

LONG-ACTING INJECTABLE MOXIDECTIN FORMULATIONS AND NOVEL MOXIDECTIN CRYSTAL FORMS

IPC classification:
A61K 31/365, A61P 33/00, C07D 493/22
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP13189094

Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases

IPC classification:
A61K 31/407, A61P 19/00, C07D 491/04
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11763973

PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2

IPC classification:
A61K 31/437, A61P 25/28, A61P 35/00, C07D 471/04
Applicant:
Genentech, Inc.
Applicant:
LifeArc
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703705

PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF

IPC classification:
A61K 31/422, A61P 33/00
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12859684

HEPATITIS B ANTIVIRAL AGENTS

IPC classification:
A61K 31/435, A61P 31/12, C07D 211/54, C07D 241/18
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13707523

TOPICAL COMPOSITIONS COMPRISING FIPRONIL AND PERMETHRIN AND METHODS OF USE

IPC classification:
A01N 43/56, A01N 53/00, A61K 31/22, A61K 31/415, A61K 47/14, A61K 47/20, A61P 33/00
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP14156495

Therapeutic vaccines

IPC classification:
A61K 39/00, A61K 39/39, C07K 14/47
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP12820937

LIPOSOMAL CHLORITE OR CHLORATE COMPOSITIONS

IPC classification:
A61K 9/127, A61K 33/20
Applicant:
Nuvo Research GmbH
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13714992

TREATMENT OF PROLIFERATIVE DISEASES WITH PYRIMIDODIAZEPINONES

IPC classification:
A61K 9/00, A61K 31/551, A61K 31/5513
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP13726299

SOLID PHASE PEPTIDE SYNTHESIS OF INSULIN USING SIDE CHAIN ANCHORED LYSINE

IPC classification:
C07K 1/04, C07K 14/62
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13778809

BIOMARKERS TO IDENTIFY PATIENTS THAT WILL RESPOND TO TREATMENT AND TREATING SUCH PATIENTS

IPC classification:
A61P 35/00, C12N 15/11, C12Q 1/68, G01N 33/574
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13727489

ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS

IPC classification:
A61K 31/047, A61K 31/137, A61K 31/196, A61K 31/421, A61K 31/593, A61P 19/00, A61P 21/02
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
GRANT OF PATENT INTENDED
EP11732517

PROCESS FRO THE PRODUCTION OF HYDROGEN

IPC classification:
B01J 31/18, B01J 31/22, C01B 3/04, C07F 15/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725424

DOSAGE REGIMEN FOR SAPACITABINE AND SELICICLIB

IPC classification:
A61K 31/505, A61K 31/52, A61K 31/706, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13719345

PARASITICIDAL COMPOSITIONS COMPRISING BENZIMIDAZOLE DERIVATIVES, METHODS AND USES THEREOF

IPC classification:
A01N 43/52, A61K 31/4184, C07D 235/10, C07D 235/18, C07D 235/28
Applicant:
Merial Limited
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP11720847

PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2

IPC classification:
A61K 31/437, A61P 25/16, C07D 401/04
Applicant:
LifeArc
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11706997

CYCLOBUTANE AND METHYLCYCLOBUTANE DERIVATIVES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 17/00, A61P 27/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Incyte Holdings Corporation
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP12737037

REACTIVE EXTRACTION PROCESS FOR REGENERATION OF AMINE-BASED SOLVENTS USED FOR CARBON DIOXIDE CAPTURE

IPC classification:
B01D 53/14, B01D 53/62, B01D 53/73, B01D 53/96, B01J 31/02
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744895

WOUND DRESSINGS COMPRISING CHLORITE

IPC classification:
A61L 15/18, A61L 15/26, A61L 15/44
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13156251

Pyrimidine derivatives as protein kinase inhibitors

IPC classification:
A61K 31/551, A61P 35/00, C07D 487/04, C07D 519/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11714200

PARASITICIDAL COMPOSITIONS COMPRISING MULTIPLE ACTIVE AGENTS, METHODS AND USES THEREOF

IPC classification:
A01N 31/02, A01N 43/00, A01N 43/56, A01N 43/60, A01N 43/90, A01N 47/02, A01N 49/00, A61K 31/231, A61K 31/365, A61K 31/4155, A61K 31/4985, A61P 33/00
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT GRANTED
EP11791699

NOVEL MONENSIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF PROTOZOAL INFECTIONS

IPC classification:
A61K 31/35, A61K 31/357, A61P 33/00, A61P 33/06, C07D 493/10, C07D 519/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT GRANTED
EP11791122

DEXAMETHASONE COMBINATION THERAPY

IPC classification:
A61K 31/5377, A61K 31/573, A61P 35/00
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT REVOKED
EP11731566

INJECTABLE PARASITICIDAL FORMULATIONS OF LEVAMISOLE AND MACROCYCLIC LACTONES

IPC classification:
A61K 9/00, A61K 31/365, A61K 31/425, A61K 31/7048, A61K 45/06, A61K 47/18, A61K 47/26, A61K 47/44, A61P 33/00, A61P 33/10
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11703989

IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS

IPC classification:
A61K 31/53, A61P 1/00, A61P 9/00, A61P 11/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Incyte Holdings Corporation
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
PATENT GRANTED
EP12705608

mTOR/JAK INHIBITOR COMBINATION THERAPY

IPC classification:
A61K 31/436, A61K 31/519, A61P 35/00
Applicant:
Novartis Pharma AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
The patent has been granted

Please Sign in to use this feature